• Title of article

    Inhibitors of VIM-2 by screening pharmacologically active and click-chemistry compound libraries Original Research Article

  • Author/Authors

    Dmitriy Minond، نويسنده , , S. Adrian Saldanha، نويسنده , , Prem Subramaniam، نويسنده , , Michael Spaargaren، نويسنده , , Timothy Spicer، نويسنده , , Joseph R. Fotsing، نويسنده , , Timo Weide، نويسنده , , Valery V. Fokin، نويسنده , , K. Barry Sharpless، نويسنده , , Moreno Galleni، نويسنده , , Carine Bebrone، نويسنده , , Patricia Lassaux، نويسنده , , Peter Hodder، نويسنده ,

  • Issue Information
    روزنامه با شماره پیاپی سال 2009
  • Pages
    11
  • From page
    5027
  • To page
    5037
  • Abstract
    VIM-2 is an Ambler class B metallo-β-lactamase (MBL) capable of hydrolyzing a broad-spectrum of β-lactam antibiotics. Although the discovery and development of MBL inhibitors continue to be an area of active research, an array of potent, small molecule inhibitors is yet to be fully characterized for VIM-2. In the presented research, a compound library screening approach was used to identify and characterize VIM-2 inhibitors from a library of pharmacologically active compounds as well as a focused ‘click’ chemistry library. The four most potent VIM-2 inhibitors resulting from a VIM-2 screen were characterized by kinetic studies in order to determine Ki and mechanism of enzyme inhibition. As a result, two previously described pharmacologic agents, mitoxantrone (1,4-dihydroxy-5,8-bis([2-([2-hydroxyethyl]amino)ethyl]amino)-9,10-anthracenedi
  • Keywords
    VIM-2 , ?-lactamase , Inhibitors
  • Journal title
    Bioorganic and Medicinal Chemistry
  • Serial Year
    2009
  • Journal title
    Bioorganic and Medicinal Chemistry
  • Record number

    1306162